We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.6B
AUM Growth
+$2.17B
Cap. Flow
-$81M
Cap. Flow %
-0.49%
Top 10 Hldgs %
31.47%
Holding
166
New
39
Increased
28
Reduced
33
Closed
30

Top Buys

Rank Stock Value
1
ARMK icon
Aramark
ARMK
+$366M
2
XLNX
Xilinx Inc
XLNX
+$332M
3
RTX icon
RTX Corp
RTX
+$299M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$289M
5
AVGO icon
Broadcom
AVGO
+$243M

Sector Composition

Rank Sector Weight
1 Healthcare 38.27%
2 Communication Services 13.23%
3 Financials 10.05%
4 Technology 9.85%
5 Industrials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IQV icon
1
IQVIA
IQV
$34.7B
$724M 4.36%
4,043,506
+516,870
+15% +$87.1M
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$633M 3.8%
7,221,880
-30,700
-0.4% -$2.59M
TMUS icon
3
T-Mobile US
TMUS
$193B
$533M 3.2%
3,949,181
+312,200
+9% +$38.6M
TMO icon
4
Thermo Fisher Scientific
TMO
$211B
$519M 3.12%
1,114,248
+18,670
+2% +$8.75M
SPY icon
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$510M 3.07%
+1,365,000
New +$484M
V icon
6
Visa
V
$677B
$487M 2.93%
2,228,104
+511,400
+30% +$105M
AON icon
7
Aon
AON
$77.3B
$480M 2.89%
2,271,514
+515,170
+29% +$105M
BSX icon
8
Boston Scientific
BSX
$65.8B
$476M 2.86%
13,238,319
+4,962,400
+60% +$179M
FIS icon
9
Fidelity National Information Services
FIS
$21.5B
$445M 2.68%
3,149,118
-13,740
-0.4% -$1.96M
ARMK icon
10
Aramark
ARMK
$15B
$424M 2.55%
+15,268,169
New +$366M
CNC icon
11
Centene
CNC
$31.3B
$411M 2.47%
6,850,000
-200,000
-3% -$12.7M
ELV icon
12
Elevance Health
ELV
$81.9B
$409M 2.46%
1,275,000
MSFT icon
13
Microsoft
MSFT
$2.84T
$391M 2.35%
1,758,168
+217,190
+14% +$46.7M
WAB icon
14
Wabtec
WAB
$51.1B
$366M 2.2%
4,997,371
-442,180
-8% -$30.2M
XLNX
15
DELISTED
Xilinx Inc
XLNX
$362M 2.18%
+2,556,000
New +$332M
CHTR icon
16
Charter Communications
CHTR
$14.7B
$362M 2.18%
546,931
-186,260
-25% -$119M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$351M 2.11%
+2,246,900
New +$289M
NYT icon
18
New York Times
NYT
$11.6B
$339M 2.04%
6,545,329
-560,713
-8% -$24.9M
XLRN
19
DELISTED
Acceleron Pharma
XLRN
$333M 2%
2,600,000
RTX icon
20
RTX Corp
RTX
$287B
$325M 1.95%
+4,542,306
New +$299M
META icon
21
Meta Platforms (Facebook)
META
$1.51T
$315M 1.9%
1,154,005
-388,040
-25% -$106M
CRM icon
22
Salesforce
CRM
$134B
$314M 1.89%
1,409,045
+710,730
+102% +$173M
TIF
23
DELISTED
Tiffany & Co.
TIF
$301M 1.81%
2,287,000
SHW icon
24
Sherwin-Williams
SHW
$78.3B
$286M 1.72%
1,168,098
-49,260
-4% -$11.7M
IOVA icon
25
Iovance Biotherapeutics
IOVA
$2.23B
$278M 1.67%
6,000,000
+45,000
+0.8% +$1.79M

Similar funds

Farallon Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Farallon Capital Management held 166 positions worth $16.6B, up 15% from $14.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Farallon Capital Management's Q4 2020 filing shows 39 new, 28 increased, 33 reduced and 30 closed positions. Its largest new stake was Aramark: 15,268,169 shares worth $424M. The largest sale was Immunomedics Inc, an estimated $498M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 41% a quarter earlier, followed by Communication Services and Financials.

  • Farallon Capital Management's largest Q4 2020 buy was Aramark: 15,268,169 shares worth $424M.
  • Farallon Capital Management added most to Willis Towers Watson in Q4 2020, an estimated $188M increase.
  • Farallon Capital Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $298M.
  • Farallon Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $498M.
  • Farallon Capital Management's ten largest holdings make up 31% of its $16.6B portfolio in Q4 2020.
  • Farallon Capital Management opened 39 new positions and closed 30 in Q4 2020.
  • Farallon Capital Management's portfolio value rose 15% quarter-over-quarter to $16.6B.

Based on Farallon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.